This post was just published on ZYX Buy Change Alert. United Therapeutics (UTHR) buyout is not likely in the near term and the risk is increasing. For this reason, it is prudent to exit the position right around here. A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help
This post was just published on ZYX Buy Change Alert. UTHR is long from $129.20. It is trading at $151.47 as of this writing. 25% of the full core position size is being held. Consider taking advantage of the strength to take profits on a 10% tranche of full core position size in
This post was just published on ZYX Buy Change Alert. UTHR has announced that it will continue the FREEDOM-EV study of Orenitram extended-release tablets. This is good news. However, many analysts were hoping for better news. A better news would have been if the effectiveness was so good that there would be
This post was just published on ZYX Buy Change Alert. UTHR is a biotech company. It closed at $127.92. There are rumors that GSK and GILD are competing to buy the company at around $200. Based on rumors the stock has moved up to $138 in the pre-market. Consider accumulating up to